A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens : a phase I trial in UK patients with EBV-positive cancer
- Submitting institution
-
The University of Birmingham
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 24117684
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-14-1122-T
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 5009
- Volume
- 20
- Issue
- 19
- ISSN
- 1078-0432
- Open access status
- Out of scope for open access requirements
- Month of publication
- August
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://clincancerres.aacrjournals.org/content/20/19/5009.figures-only
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 59
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Corresponding author
- Non-English
- No
- English abstract
- -
